Pfizer Inc (CHIX:PFEd) Stock News, Headlines & Updates
Pfizer Inc Stock News from GuruFocus
- 1
- 2
- 3
Jul 16, 2025
Pfizer (PFE) Sees Surge in Bullish Options Activity | PFE Stock News
GuruFocus News • 11:00am
Jul 14, 2025
ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression | PFE Stock New
GuruFocus News • 8:45am
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment | PFE Stock News
GuruFocus News • 8:45am
Jul 10, 2025
Pfizer (PFE) and BioNTech Appeal Patent Ruling Favoring Moderna
GuruFocus News • 7:58am
Pfizer (PFE) and Astellas's Xtandi Achieves Key Milestone in Prostate Cancer Study
GuruFocus News • 6:57am
Pfizer (PFE) Announces Positive Results from Prostate Cancer Drug Study | PFE Stock News
GuruFocus News • 6:18am
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence | PFE Stock News
GuruFocus News • 6:00am
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Business Wire • 6:00am
Jul 08, 2025
Pfizer's (PFE) Executive Transition: Sally Susman to Depart After 18 Years
GuruFocus News • 10:56am
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025 | PFE Stock News
GuruFocus News • 8:45am
Jul 02, 2025
CDC Endorsement Boosts Pfizer (PFE) in RSV Vaccine Market
GuruFocus News • 2:55pm
Jul 01, 2025
Pfizer (PFE) Halts Phase 2 Trial of Maplirpacept Amid Recruitment Issues
GuruFocus News • 12:56pm
Pfizer Inc (PFE) Stock Price Up 3.3% on Jul 1
GuruFocus News • 12:03pm
Jun 26, 2025
Pfizer's (PFE) Hympavzi Shows Promise in Hemophilia Trial
GuruFocus News • 6:56am
Pfizer (PFE) Reports Promising Phase 3 Study Results for Hemophilia Drug | PFE Stock News
GuruFocus News • 6:16am
Pfizer Inc (PFE) Announces Positive Phase 3 Results for HYMPAVZIâ„¢ in Hemophilia Treatment | PFE stock news
GuruFocus News • 6:02am
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZIâ„¢ in Hemophilia A or B with Inhibitors | PFE Stock News
GuruFocus News • 6:00am
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZIâ„¢ in Hemophilia A or B with Inhibitors
Business Wire • 6:00am
Jun 25, 2025
Pfizer Inc (PFE) Declares Third-Quarter 2025 Dividend | PFE stock news
GuruFocus News • 6:03pm
Pfizer Declares Third-Quarter 2025 Dividend
Business Wire • 5:00pm
Pfizer (PFE) Announces Consistent Quarterly Dividend
GuruFocus News • 4:55pm
Pfizer Declares Third-Quarter 2025 Dividend | PFE Stock News
GuruFocus News • 4:45pm
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts
Business Wire • 10:00am
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts | PFE Stock News
GuruFocus News • 9:17am
Jun 17, 2025
Pfizer (PFE) Experiences Moderate Bearish Sentiment Among Option Traders | PFE Stock News
GuruFocus News • 11:45am
Jun 16, 2025
Pfizer (PFE) Experiences Mixed Options Sentiment Amidst Price Drop | PFE Stock News
GuruFocus News • 12:00pm
Big Pharma's $18.3B Secret: Why U.S. Drug Giants Are Flooding China With Licensing Deals
Khac Phu Nguyen • 9:08am
Jun 14, 2025
FDA Denies Pfizer's (PFE) Label Expansion for Talzenna in Prostate Cancer
GuruFocus News • 9:55am
Jun 13, 2025
Pfizer (PFE) Option Activity Shows Mixed Sentiment | PFE Stock News
GuruFocus News • 1:15pm
Jun 12, 2025
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
Marketwired • 3:00pm
Jun 11, 2025
Pfizer (PFE) Sees Mixed Options Sentiment Amidst Modest Share Increase | PFE Stock News
GuruFocus News • 1:15pm
Jun 10, 2025
RFK Jr.'s Committee Shake-up Leaves Vaccine Stocks Flat
GuruFocus News • 2:56pm
Pfizer's (PFE) Quest for Clarity on Drug Pricing Plan
GuruFocus News • 2:56pm
Pfizer (PFE) Meets with Administration to Discuss Drug Prices | PFE Stock News
GuruFocus News • 9:03am
Jun 09, 2025
Pfizer (PFE) Sees Surge in Bullish Options Activity Ahead of Earnings | PFE Stock News
GuruFocus News • 10:00am
Jun 04, 2025
PFE: Upcoming Investor Meetings in Kansas City and St. Louis | PFE Stock News
GuruFocus News • 4:30pm
Jun 03, 2025
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
PRNewswire • 5:00pm
Jun 02, 2025
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Business Wire • 10:00am
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference | PFE Stock News
GuruFocus News • 9:16am
May 31, 2025
Pfizer and Arvinas Plan FDA Submission for Breast Cancer Drug
GuruFocus News • 9:55am
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news